SEI Investments’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-28,131
| Closed | -$3.61M | – | 2831 |
|
|
2025
Q2 | $3.61M | Sell |
28,131
-42,332
| -60% | -$4.4M | ﹤0.01% | 1399 |
|
|
2025
Q1 | $6.24M | Buy |
70,463
+79
| +0.1% | +$7.71K | 0.01% | 1170 |
|
|
2024
Q4 | $6.14M | Buy |
70,384
+6,411
| +10% | +$587K | 0.01% | 1202 |
|
|
2024
Q3 | $5.92M | Buy |
63,973
+10,987
| +21% | +$1.09M | 0.01% | 1209 |
|
|
2024
Q2 | $5.71M | Buy |
52,986
+7,073
| +15% | +$708K | 0.01% | 1175 |
|
|
2024
Q1 | $4.35M | Buy |
45,913
+12,311
| +37% | +$1.06M | 0.01% | 1268 |
|
|
2023
Q4 | $3.1M | Buy |
33,602
+5,502
| +20% | +$356K | 0.01% | 1406 |
|
|
2023
Q3 | $1.41M | Buy |
28,100
+9,502
| +51% | +$508K | ﹤0.01% | 1753 |
|
|
2023
Q2 | $1.18M | Buy |
18,598
+4,413
| +31% | +$240K | ﹤0.01% | 1830 |
|
|
2023
Q1 | $638K | Buy |
14,185
+2,722
| +24% | +$123K | ﹤0.01% | 2043 |
|
|
2022
Q4 | $502K | Buy |
11,463
+2,412
| +27% | +$116K | ﹤0.01% | 2001 |
|
|
2022
Q3 | $596K | Sell |
9,051
-1,011
| -10% | -$64.9K | ﹤0.01% | 2004 |
|
|
2022
Q2 | $508K | Sell |
10,062
-13,048
| -56% | -$764K | ﹤0.01% | 2094 |
|
|
2022
Q1 | $1.48M | Sell |
23,110
-11,896
| -34% | -$854K | ﹤0.01% | 1657 |
|
|
2021
Q4 | $3.75M | Sell |
35,006
-377
| -1% | -$39.4K | 0.01% | 1286 |
|
|
2021
Q3 | $3.64M | Sell |
35,383
-1,803
| -5% | -$168K | 0.01% | 1248 |
|
|
2021
Q2 | $3.27M | Sell |
37,186
-36,587
| -50% | -$3.35M | 0.01% | 1279 |
|
|
2021
Q1 | $7.33M | Buy |
73,773
+15,073
| +26% | +$1.5M | 0.02% | 816 |
|
|
2020
Q4 | $6.58M | Sell |
58,700
-65,366
| -53% | -$6.89M | 0.02% | 838 |
|
|
2020
Q3 | $11.5M | Buy |
124,066
+8,374
| +7% | +$645K | 0.03% | 494 |
|
|
2020
Q2 | $9.03M | Buy |
115,692
+58,528
| +102% | +$3.96M | 0.03% | 588 |
|
|
2020
Q1 | $3.34M | Buy |
57,164
+7,188
| +14% | +$463K | 0.01% | 929 |
|
|
2019
Q4 | $4M | Buy |
49,976
+2,568
| +5% | +$192K | 0.01% | 1019 |
|
|
2019
Q3 | $3.48M | Buy |
47,408
+22,821
| +93% | +$1.97M | 0.01% | 1086 |
|
|
2019
Q2 | $2.32M | Sell |
24,587
-5,451
| -18% | -$450K | 0.01% | 1268 |
|
|
2019
Q1 | $2.4M | Sell |
30,038
-13,293
| -31% | -$982K | 0.01% | 1235 |
|
|
2018
Q4 | $3.37M | Sell |
43,331
-9
| -0% | -$547 | 0.01% | 1091 |
|
|
2018
Q3 | $3.38M | Buy |
43,340
+1,833
| +4% | +$127K | 0.01% | 1058 |
|
|
2018
Q2 | $2.63M | Buy |
41,507
+10,437
| +34% | +$831K | 0.01% | 1220 |
|
|
2018
Q1 | $2.85M | Sell |
31,070
-43,438
| -58% | -$3.74M | 0.01% | 1073 |
|
|
2017
Q4 | $5.62M | Buy |
74,508
+15,257
| +26% | +$1.07M | 0.02% | 852 |
|
|
2017
Q3 | $4.13M | Buy |
59,251
+23,151
| +64% | +$1.24M | 0.01% | 964 |
|
|
2017
Q2 | $1.83M | Buy |
+36,100
| New | +$1.53M | 0.01% | 1227 |
|
Other funds holding BPMC
IA
HNB
SEI Investments's BPMC Position: Q3 2025 in Review
SEI Investments sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 28,131 shares — an estimated $3.61M sold.
SEI Investments first reported a position in BPMC in Q2 2017 and held it in 33 quarters. The position peaked at $11.5M in Q3 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- SEI Investments reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- SEI Investments sold 28,131 Blueprint Medicines shares in Q3 2025, an estimated $3.61M.
- SEI Investments first reported a position in Blueprint Medicines in Q2 2017 and held it in 33 quarters.
- SEI Investments's Blueprint Medicines position peaked at $11.5M in Q3 2020.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on SEI Investments's 13F filing for Q3 2025, filed 13 Nov 2025.